What is a 503B outsourcing facility, and why are so many of them uninspected by FDA? Partnership for Safe Medicines The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to Convene Pharmacy Compounding Advisory Committee in July BPC 157 Complete Guide: Dosing & 2026 Status The Peptide Toolkit Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy Is BPC 157 Banned? Oral vs. Injectable Forms Explained